BiVACOR’s Post

We’re incredibly proud of BiVACOR, who have announced Australia’s first implant of its Total Artificial Heart as a clinical success!   The patient was the first in the world to be discharged home with the device while awaiting a heart transplant.    After 104 days on the BiVACOR Total Artificial Heart, he received a donor heart and successfully underwent transplant surgery. He is the longest-supported patient on the device, celebrating another birthday, Christmas and New Year with his friends and family, free from heart failure symptoms.   “Being able to bring Australia along this journey and be part of the first clinical trials is immensely important to me and something that I set out to do from the very beginning,” says Dr. Daniel Timms, BiVACOR Founder & CTO.   The BiVACOR Total Artificial Heart is designed to replace the native heart's function entirely, acting as a bridge to keep patients alive until a donor heart becomes available.    Huge congratulations to Daniel Timms, William Cohn, Dr. Paul Jansz, Prof. Chris Hayward, and the teams at BiVACOR and St Vincent's Health Australia for their extraordinary work in achieving these milestones.   Learn more about this Australian-first achievement 👉 https://lnkd.in/gDWif272